retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Lilly's delivers up to 71.2 lbs of weight loss Retatrutide 10mg — Triple Receptor
Description
I'm gonna talk about GLP ones, but I'm not a cheerleader for GLP ones
However, 47% of those with diabetes and 36% with obesity who discontinued these medications restarted them again within a year
J Clin Exp Hepatol 2022;12:1057-1068
Zepbound (tirzepatide): Once-weekly injectable
Rochester CD, Akiyode O
Effects of DPP-4i on HF DPP-4 has been shown to directly increase factors that are predominant in HF
